In vitro and in vivo studies have demonstrated that decreased GAS5 expression in human HCC cell lines induces cell proliferation and migration, thus indicating the role of GAS5 in tumor suppression and as a therapeutic target in HCC [50,51]. The gene discussed is GAS5; the disease is neoplasm.